EP3461260A4 - Compositions comprenant de la l-théanine, une ou des proanthocyanidine(s) et une cathéchine, et utilisations de celles-ci - Google Patents

Compositions comprenant de la l-théanine, une ou des proanthocyanidine(s) et une cathéchine, et utilisations de celles-ci Download PDF

Info

Publication number: EP3461260A4
Authority: EP; European Patent Office
Prior art keywords: proanthocyanidin; theanine; catechin; compositions
Prior art date: 2016-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP17799731.9A

Other languages

German (de)

English (en)

Other versions

EP3461260A1 (fr

Inventor

Andrew Belton Scholey

Angus Ross BROWN

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alphagen Nz Ltd

Original Assignee

Alphagen Nz Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-05-17

Filing date

2017-05-11

Publication date

2020-02-12

2017-05-11 Application filed by Alphagen Nz Ltd filed Critical Alphagen Nz Ltd

2017-05-11 Priority claimed from PCT/NZ2017/050058 external-priority patent/WO2017200391A1/fr

2019-04-03 Publication of EP3461260A1 publication Critical patent/EP3461260A1/fr

2020-02-12 Publication of EP3461260A4 publication Critical patent/EP3461260A4/fr

Status Withdrawn legal-status Critical Current

Links

PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 title 1
JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 title 1
229920001991 Proanthocyanidin Polymers 0.000 title 1
ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 title 1
235000005487 catechin Nutrition 0.000 title 1
229950001002 cianidanol Drugs 0.000 title 1
DATAGRPVKZEWHA-UHFFFAOYSA-N l-theanine Chemical compound CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP17799731.9A 2016-05-17 2017-05-11 Compositions comprenant de la l-théanine, une ou des proanthocyanidine(s) et une cathéchine, et utilisations de celles-ci Withdrawn EP3461260A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ16720245		2016-05-17
PCT/NZ2017/050058 WO2017200391A1 (fr)	2016-05-17	2017-05-11	Compositions comprenant de la l-théanine, une ou des proanthocyanidine(s) et une cathéchine, et utilisations de celles-ci

Publications (2)

Publication Number	Publication Date
EP3461260A1 EP3461260A1 (fr)	2019-04-03
EP3461260A4 true EP3461260A4 (fr)	2020-02-12

Family

ID=65479760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17799731.9A Withdrawn EP3461260A4 (fr)	2016-05-17	2017-05-11	Compositions comprenant de la l-théanine, une ou des proanthocyanidine(s) et une cathéchine, et utilisations de celles-ci

Country Status (1)

Country	Link
EP (1)	EP3461260A4 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006126895A2 (fr) *	2005-05-23	2006-11-30	Mathias Alfons Everhard Frevel	Agent ameliorant les capacites cognitives
WO2007109802A2 (fr) *	2006-03-23	2007-09-27	Herbalscience Singapore Pte. Ltd.	Extraits de l'espèce de thé vert et méthodes de préparation de ces derniers
US20070248696A1 (en) *	2006-04-25	2007-10-25	Mind Sports Nutrition Inc.	Composition and method for enhancing neuromuscular facilitation and cognitive functions
JP2011168523A (ja) *	2010-02-18	2011-09-01	Toyo Shinyaku Co Ltd	月経前症候群に起因する症状緩和剤およびその症状緩和剤を含有する飲食品
CN104432063A (zh) *	2014-12-18	2015-03-25	北京康比特体育科技股份有限公司	一种缓解运动性疲劳的组合物及其制剂

2017
- 2017-05-11 EP EP17799731.9A patent/EP3461260A4/fr not_active Withdrawn

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006126895A2 (fr) *	2005-05-23	2006-11-30	Mathias Alfons Everhard Frevel	Agent ameliorant les capacites cognitives
WO2007109802A2 (fr) *	2006-03-23	2007-09-27	Herbalscience Singapore Pte. Ltd.	Extraits de l'espèce de thé vert et méthodes de préparation de ces derniers
US20070248696A1 (en) *	2006-04-25	2007-10-25	Mind Sports Nutrition Inc.	Composition and method for enhancing neuromuscular facilitation and cognitive functions
JP2011168523A (ja) *	2010-02-18	2011-09-01	Toyo Shinyaku Co Ltd	月経前症候群に起因する症状緩和剤およびその症状緩和剤を含有する飲食品
CN104432063A (zh) *	2014-12-18	2015-03-25	北京康比特体育科技股份有限公司	一种缓解运动性疲劳的组合物及其制剂

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Enzogenol - Chemistry of the ENZOGENOL Pine Bark Extract", 10 December 2019 (2019-12-10), XP055651403, Retrieved from the Internet <URL:https://www.enzogenol.com/research/composition> [retrieved on 20191210] *
DATABASE WPI Week 201160, Derwent World Patents Index; AN 2011-L09223, XP002796439 *
DATABASE WPI Week 201535, Derwent World Patents Index; AN 2015-29035P, XP002796438 *
ENZO: "Understanding the Basics", 31 October 2015 (2015-10-31), XP055651483, Retrieved from the Internet <URL:https://www.enzo.co.nz/site/enzo/brochures/ENZO%20Relax%20&%20Focus%20Trifold%202015_lowres.pdf> [retrieved on 20191210] *
JUSTIN D ROBERTS ET AL: "The effect of a decaffeinated green tea extract formula on fat oxidation, body composition and exercise performance", JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, BIOMED CENTRAL LTD, LO, vol. 12, no. 1, 21 January 2015 (2015-01-21), pages 1, XP021210078, ISSN: 1550-2783, DOI: 10.1186/S12970-014-0062-7 *
See also references of WO2017200391A1 *

Also Published As

Publication number	Publication date
EP3461260A1 (fr)	2019-04-03

Legal Events

Date	Code	Title	Description
2017-11-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2019-03-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2019-03-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-04-03	17P	Request for examination filed	Effective date: 20181113
2019-04-03	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-04-03	AX	Request for extension of the european patent	Extension state: BA ME
2019-08-21	DAV	Request for validation of the european patent (deleted)
2019-08-21	DAX	Request for extension of the european patent (deleted)
2020-01-22	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 36/87 20060101ALI20191218BHEP Ipc: A61K 36/82 20060101AFI20191218BHEP Ipc: A61P 25/24 20060101ALI20191218BHEP Ipc: A61P 25/22 20060101ALI20191218BHEP Ipc: A61K 31/198 20060101ALI20191218BHEP Ipc: A61K 36/45 20060101ALI20191218BHEP Ipc: A61K 36/15 20060101ALI20191218BHEP Ipc: A61K 31/353 20060101ALI20191218BHEP
2020-02-12	A4	Supplementary search report drawn up and despatched	Effective date: 20200113
2020-12-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2021-01-27	18D	Application deemed to be withdrawn	Effective date: 20200811

Publication	Publication Date	Title
EP3368086A4 (fr)	2019-12-04	Adhésifs cutanés, compositions antimicrobiennes, articles et procédés d'utilisation de ceux-ci
EP3732091B8 (fr)	2023-11-22	Profils aérodynamiques et machines incorporant des profils aérodynamiques
EP3280578A4 (fr)	2019-01-02	Articles antimicrobiens et composés associés
EP3287390A4 (fr)	2019-01-02	Emballage à ouverture par arrachage et structure d'ouverture pour emballage à ouverture par arrachage
EP3381925A4 (fr)	2018-10-03	Dérivés de brigatinib modifiés par deutérium, compositions pharmaceutiques les contenant et utilisation correspondante
EP3275454A4 (fr)	2018-02-14	Composition pharmaceutique contenant de la silybine, ve et l-carnitine
IL261782A (en)	2018-10-31	Carbapenem compounds, preparations containing them and their uses
EP3720844A4 (fr)	2021-08-11	Compositions de médicaments
EP3109242B8 (fr)	2019-02-27	Dérivés de taxane solubles dans l'eau et leurs utilisations
EP3145313A4 (fr)	2018-02-21	Composition antimicrobienne pour protéger le bois
EP3692094A4 (fr)	2021-06-23	Composition aqueuse de polymère
EP3496714A4 (fr)	2020-04-22	Compositions de médicaments.
EP3388460A4 (fr)	2019-05-22	Composé oxazine, composition et produit durci
EP3320785A4 (fr)	2019-04-10	Composition, contenant des extraits dedipsacus asperoides
EP3283105A4 (fr)	2018-12-19	Composition de vaccin et ses utilisations
EP3300474A4 (fr)	2019-01-30	Compositions à base de bêta-cryptoxanthine, ses procédés de préparation et ses utilisations
EP3247323A4 (fr)	2018-07-11	Composition de chlorophylle
EP3283060A4 (fr)	2018-12-19	Compositions, composés bolaamphiphiles, et leurs utilisations
EP3271335B8 (fr)	2019-03-27	Dérivé de 1,4-bis (3-aminopropyl)pipérazine et utilisation de celui-ci
EP3461260A4 (fr)	2020-02-12	Compositions comprenant de la l-théanine, une ou des proanthocyanidine(s) et une cathéchine, et utilisations de celles-ci
IL259900A (en)	2018-07-31	Aminoazole derivatives, compositions containing same and uses thereof
EP3268002B8 (fr)	2020-10-28	Compositions antibactériennes et méthodes
EP3153163A4 (fr)	2017-05-17	Composé pharmaceutique contenant 13 glycérides, sa formulation et son utilisation
HK40039946B (en)	2023-06-23	Compositions including pine bark extract, berryfruit extract and a source of l-theanine and uses thereof
HK40031770A (en)	2021-03-12	Compounds, compositions and methods